The contract award details a delivery order valued at $19,210.47 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the drug KISQALI 600 mg daily dose 63s, a medication used for the treatment of breast cancer. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The award supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.
Generated 3/3/25, 12:30 PM